Technology

The NBX Platform™ is a proprietary microbial system optimized for high-yield, high-quality plasmid DNA production.

NBX demonstrates higher yields, shorter run times, and better quality than standard E. coli systems. It is fully compatible with existing workflows and integrates seamlessly into streamlined drug development processes. Its scalability from research to clinical-scale production makes it an ideal solution at every stage of development.

Higher yield

Half the time

Higher quality

Lower endotoxins

Compatible with E. coli infrastructure

Scalable to large-scale pDNA production

Applications:

  • Gene and cell therapy

  • RNA therapeutics

  • Nucleic acid vaccines

  • Much more

Higher yield

Faster growth

Better quality

Time to say goodbye to E. coli?

Download the NBX white paper

NBX opens opportunities for faster commercialization of high-demand gene therapies and vaccines in an industry increasingly hungry for DNA.